| Literature DB >> 28752410 |
Annastazia E Learoyd1, Lisa Woodhouse2, Laurence Shaw3, Nikola Sprigg2, Daniel Bereczki4, Eivind Berge5, Valeria Caso6, Hanne Christensen7, Ronan Collins8, Anna Czlonkowska9, Anwar El Etribi10, Tracy D Farr1, John Gommans11, Ann-Charlotte Laska12, George Ntaios13, Serefnur Ozturk14, Stuart J Pocock15, Kameshwar Prasad16, Joanna M Wardlaw17, Kevin C Fone1, Philip M Bath2, Rebecca C Trueman18.
Abstract
Early infection after stroke is associated with a poor outcome. We aimed to determine whether delayed infections (up to 76 days post-stroke) are associated with poor outcome at 90 days. Data came from the international Efficacy of Nitric Oxide Stroke (ENOS, ISRCTN99414122) trial. Post hoc data on infections were obtained from serious adverse events reports between 1 and 76 days following stroke in this large cohort of patients. Regression models accounting for baseline covariates were used to analyse fatalities and functional outcomes (modified Rankin Scale (mRS), Barthel Index, Euro-Qol-5D) at 90 days, in patients with infection compared to those without infection. Of 4011 patients, 242 (6.0%) developed one or more serious infections. Infections were associated with an increased risk of death (p < 0.001) and an increased likelihood of dependency (measured by mRS) compared to those of all other patients (p < 0.001). This remained when only surviving patients were analysed, indicating that the worsening of functional outcome is not due to mortality (p < 0.001). In addition, the timing of the infection after stroke did not alter its detrimental association with fatality (p = 0.14) or functional outcome (p = 0.47). In conclusion, severe post-stroke infections, whether occurring early or late after stroke, are associated with an increased risk of death and poorer functional outcome, independent of differences in baseline characteristics or treatment. Not only are strategies needed for reducing the risk of infection immediately after stroke, but also during the first 3 months following a stroke. This study is registered: ISRCTN registry, number ISRCTN99414122, ClinicalTrials.gov Identifier, NCT00989716.Entities:
Keywords: Disability; Glyceryl trinitrate; Infection; Stroke
Mesh:
Substances:
Year: 2017 PMID: 28752410 PMCID: PMC5818141 DOI: 10.1007/s12975-017-0553-3
Source DB: PubMed Journal: Transl Stroke Res ISSN: 1868-4483 Impact factor: 6.829